Tickerplace logo

Tickerplace

Mineralys Therapeutics, Inc. logo

MLYSMineralys Therapeutics, Inc.

MLYS Stock Price, Valuation & Chart | Mineralys Therapeutics, Inc.

Compare
$29.040+3.47 (+13.57%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyMLYS intrinsic valueMLYS calculated fair value vs price
OverviewFinancialsDividendsRatios

MLYS Historical price chart

MLYS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization2.56B
PE Ratio-6.85
EPS-4.24
Trading Volume2.04M
Today's High/Low29.29/25.7
Dividend Yield0.00
52 Week High/Low47.65/22.3
Shares Outstanding88.16M
MLYS Financial Statement
MLYS Analyst ratings
MLYS Analysis & performance metrics

MLYS Company profile

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It…

MLYS Management team

Management
Robert McKean Ph.D.
Senior Vice President of CMC
Jeffrey N. Fellows
Senior Vice President of Regulatory Affairs
Jessica Ibbitson
Senior Vice President of Clinical Operations
Danielle Bradbury
Senior Vice President of Quality Assurance
Sarah Foster
Vice President of Human Resources
Jon CongletonCEO
President, Chief Executive Officer & Director
Adam Scott LevyCFO
Chief Financial Officer & Secretary
Brian Taylor Slingsby M.D., M.P.H., Ph.D.CTO
Founder & Executive Director
Total 8 executives

MLYS Frequently asked questions

What is Mineralys Therapeutics, Inc. (MLYS) Stock Price?

Current stock price of Mineralys Therapeutics, Inc. (MLYS) stock is $29.040. The stock price is +13.57% higher in the session. The intraday range can be seen from this page. Volume of Mineralys Therapeutics, Inc. (MLYS) stock is 2.04M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Mineralys Therapeutics, Inc. (MLYS) stock price going up or down today?

The stock price of Mineralys Therapeutics, Inc. (MLYS) can change with earnings, company news, and overall market sentiment. Mineralys Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Mineralys Therapeutics, Inc. stock expensive at its current price?

Whether Mineralys Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MLYS on this page is -6.85. EPS on this page is -4.24. Compare those figures with peers and growth expectations before deciding if the current Mineralys Therapeutics, Inc. price is justified.

How has the stock price of Mineralys Therapeutics, Inc. (MLYS) performed historically?

Historical performance for Mineralys Therapeutics, Inc. (MLYS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MLYS reacted to past earnings and market events.

Should I buy Mineralys Therapeutics, Inc. (MLYS) stock, at this price?

Buying Mineralys Therapeutics, Inc. (MLYS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.